In early December, Coriell's president and CEO, Michael Christman, PhD, delivered the 2011 Ullyot Public Affairs Lecture. Dr. Christman's engaging lecture, which was open to the public, focused on the use of genetic information in the delivery of medical care. Personalized medicine can offer patients several advantages, including the ability to make better-informed clinical decisions and use better-targeted therapies for a higher probability of desired health outcomes; reduce the chance of adverse reactions from medications and treatments; focus on the prediction and prevention of disease; and, reduce healthcare costs. Dr. Christman also shared his thoughts on a number of ethical, legal, and social challenges that must be addressed to realize the full potential of personalized medicine.
The audience expressed great appreciation to Dr. Christman and the Chemical Heritage Foundation for the providing this stimulating and timely lecture; indeed, they posed a wide range of questions from the role of nutrition to the accurate treatment of complex diseases, and the ethical issue of predicting a disease like Alzheimer's.
Dr. Christman and Coriell Institute are most grateful to Tom Tritton, president and CEO of the Chemical Heritage Foundation for the opportunity and honor to deliver this year's Ullyot Public Affairs Lecture.
Pictured here: Preston Moore (left), member of the Ullyot Committee and representative of the Delaware section of the American Chemical Society, and Tom Tritton (right), president and CEO of CHF, presenting the Philadelphia Bowl to Michael Christman, PhD, (center), the 2011 Ullyot Public Affairs Lecturer.
Support research at Coriell. Let’s find answers together.
